Drug- or toxin-induced pulmonary arterial hypertension
MONDO:0017149Drug- or toxin-induced pulmonary arterial hypertension (PAH) is a form of pulmonary arterial hypertension (PAH) secondary to the exposition to drugs. Drug- or toxin-induced PAH is characterized by elevated pulmonary arterial resistance leading to right heart failure. Drug or toxin induced PAH is progressive and potentially fatal.
Also known as: drug- or toxin-induced PAH
26 clinical trials for this condition and its sub-types, 4 tagged with Drug- or toxin-induced pulmonary arterial hypertension itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Fat in the heart: new clues for PAH?
Knowledge-focused Recruiting nowThis study examines why fat accumulates in the right ventricle of people with pulmonary arterial hypertension (PAH) and how it affects heart function and exercise ability. Researchers will use MRI and blood tests in 75 adults with PAH to track changes over time. The goal is to be…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Scientists probe hidden links between hormones and lung disease
Knowledge-focused Recruiting nowThis study looks at how hormones and metabolism are involved in pulmonary arterial hypertension (PAH), a serious lung condition. Researchers will measure sex hormone levels, insulin resistance, and test two potential treatments—metformin and ACE-2—in small groups. The goal is to …
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:37 UTC